PCSK9 Inhibition in Subjects With Elevated Risk

 

FOURIER - Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk.

Interview with Professor Peter Sever from Imperial College London, London, UK at ACC 2017.